BGJ398
Description: An anticancer drug, also known as infigratinib, that inhibits fibroblast growth factor receptors, particularly FGFR1–3.
Primary topic: Fibroblast Growth Factor Research (33%)
Wikidata ID: wiki/Q27075200
OpenAlex ID: keywords/bgj398
